← Browse by Condition
Medical Condition
pancreatic ductal adenocarcinoma
Total Trials
17
Recruiting Now
17
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for pancreatic ductal adenocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — pancreatic ductal adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for pancreatic ductal adenocarcinoma?
ClinicalMetric currently tracks 17 actively recruiting clinical trials for pancreatic ductal adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 17. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pancreatic ductal adenocarcinoma?
pancreatic ductal adenocarcinoma research spans Phase 1 (7 trials), Phase 2 (7 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pancreatic ductal adenocarcinoma clinical trial?
Eligibility criteria for pancreatic ductal adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 7
Phase 2 7
Phase 3 2
Top Sponsors
3 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05254171 Phase 2, Phase 3
Recruiting
Enrollment
600 pts
Location
United States, Austr...
Sponsor
Panbela Therapeutics, Inc.
NCT07284277 Phase 1, Phase 2
Recruiting
Enrollment
30 pts
Location
Spain
Sponsor
Clinica Universidad de Navarra...
NCT06275737
Recruiting
Enrollment
72 pts
Location
France
Sponsor
GERCOR - Multidisciplinary Onc...
NCT04146298 Phase 1, Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Changhai Hospital
NCT05314998 Phase 3
Recruiting
Enrollment
394 pts
Location
Germany, Sweden
Sponsor
John Neoptolemos
NCT07155525
Recruiting
Enrollment
194 pts
Location
Egypt
Sponsor
Minia University
NCT07252076
Recruiting
Enrollment
120 pts
Location
Italy
Sponsor
Azienda Ospedaliera SS. Antoni...
NCT06756074 Phase 2
Recruiting
Enrollment
100 pts
Location
Egypt
Sponsor
Minia University
NCT06287749
Recruiting
Enrollment
37 pts
Location
France
Sponsor
University Hospital, Montpelli...
NCT06131840 Phase 1
Recruiting
Enrollment
914 pts
Location
United States, Canad...
Sponsor
Seagen, a wholly owned subsidi...
NCT07226154
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06084481 Phase 1
Recruiting
Enrollment
325 pts
Location
United States, Austr...
Sponsor
AbbVie
NCT07629960 Phase 1, Phase 2
Recruiting
Enrollment
265 pts
Location
United States, Spain
Sponsor
Blueprint Medicines Corporatio...
NCT06710756 Phase 1, Phase 2
Recruiting
Enrollment
112 pts
Location
United States
Sponsor
Perspective Therapeutics
NCT04291651
Recruiting
Enrollment
4,000 pts
Location
United States
Sponsor
University of California, San ...
NCT07328607
Recruiting
Enrollment
90 pts
Location
Egypt
Sponsor
Minia University
NCT06598007 Phase 1, Phase 2
Recruiting
Enrollment
78 pts
Location
United States
Sponsor
Crossignal Therapeutics, Inc.
Related Conditions
pancreatic cancer (3) esophageal cancer (2) pancreatic neoplasms (2) colorectal neoplasms (2) colorectal cancer (2) pancreatic cancer metastatic (1) pancreatic cancer stage iv (1) pancreatic adenocarcinoma metastatic (1) advanced cancer (1) periampullary cancer (1) duodenal cancer (1) cholangiocarcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology